Milos Miljkovic
Fortuna: 87 882 $ al 30/06/2026
Fortuna: 87 882 $ al 30/06/2026
Milos Miljkovic served as Chief Medical Officer at Cartesian Therapeutics, Inc. (United States) from 2021 to 2023.
Dr. Miljkovic also served as Chief Medical Officer at Cartesian Therapeutics, Inc. from 2023 to 2026.
Former job(s) include Chief Medical Officer at Cartesian Therapeutics, Inc. (United States) and Cartesian Therapeutics, Inc.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
0,03 % | 14/04/2026 | 8.434 ( 0,03 % ) | 87 882 $ | 30/06/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
Cartesian Therapeutics, Inc.
Cartesian Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage company that develops mRNA cell therapies for autoimmune diseases | Director Técnico/Científico/I+D | 13/11/2023 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 1 |
|---|---|
Cartesian Therapeutics, Inc.
Cartesian Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage company that develops mRNA cell therapies for autoimmune diseases | Commercial Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.